Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]
Phase 4 clinical trial evaluating erlotinib in patients with advanced non-small cell lung cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: A Phase 1 Study in Participants With Advanced Cancer [Phase 1]
A Phase 1 trial sponsored by Eli Lilly in participants with advanced cancer, including anal squamous cell carcinoma, head and neck squamous …
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients [Phase 2]
Phase 2 clinical trial update reporting on the efficacy and safety of dendritic cytotoxic lymphocyte (DC-CTL) cell infusion in patients with…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase I study evaluating the combination of Sutent (sunitinib) and Rapamune (sirolimus) in advanced Non-Small Cell Lung Cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating selenium for preventing tumor growth in patients with previously resected stage I non-small cell lung cancer has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of quisinostat in combination with chemotherapy in patients with non…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC [Phase 1]
A Phase 1 trial evaluating gated intensity-modulated radiation therapy with concurrent chemotherapy for inoperable non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial comparing pemetrexed plus gefitinib versus gefitinib alone in non-small cell lung cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer [Phase 2]
This ClinicalTrials.gov update reports the termination of a Phase 2 study evaluating pemetrexed with radiation for poor-risk Stage III non-s…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. [Phase 4]
Phase 4 trial assessing Avastin (bevacizumab) with platinum-based chemotherapy in advanced or recurrent non-squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Combination of Chemotherapy and Gefitinib as First-line Treatment [NA]
The document notes the completion of a clinical trial evaluating the combination of chemotherapy and gefitinib as first-line treatment for n…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase II Avastin Trial for Stage IIIB/IV NSCLC [Phase 2]
A Phase II trial of Avastin (bevacizumab) for stage IIIB/IV non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study update for BIND-014, a docetaxel nanoparticle formulation, in second-line non-small cell lung cancer (KRAS-positive and squamo…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of BIND-014, a docetaxel nanoparticle formulation, as second-line therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC [Phase 2]
Phase 2 study of carboplatin, pemetrexed, and panitumumab in advanced non-squamous KRAS wild-type non-small cell lung cancer has completed a…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?
This trial update notes the completion of a study evaluating whether epidermal growth factor receptor (EGFR)–targeted therapy can improve su…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva) [Phase 1]
Phase 1 trial evaluating how itraconazole affects the pharmacokinetics of AZD9291 (osimertinib) in patients with EGFR-positive non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation [Phase 1]
Phase 1 clinical trial assessing whether Chinese herbal therapy based on syndrome differentiation can reduce chemotherapy toxicity while enh…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of combining apatinib with etoposide in heavily pretreated patients with advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen-sponsored trial evaluating neutropenia and anemia management in patients with solid tumors receiving myelotoxic chemotherapy has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial update examining the effect of food on AZD9291 (osimertinib) blood levels in patients with advanced non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) [Phase 1]
Phase I imaging trial evaluating dalotuzumab in combination with erlotinib for non-small cell lung cancer; the MK-0646-008 study has complet…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. [Phase 2]
Phase 2 study evaluating Tarceva (erlotinib) in combination with Gemcitabine in treatment-naive patients with advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer [Phase 4]
A Phase 4 clinical trial update describes an intercalated regimen of chemotherapy and tyrosine kinase inhibitors as first-line treatment for…